Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDL

The hypothesis that raising high-density lipoprotein cholesterol (HDL-C) levels could improve the risk for cardiovascular disease (CVD) is facing challenges. There is multitudinous clear clinical evidence that the latest failures of HDL-C-raising drugs show no clear association with risks for CVD. A...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Peiqiu Cao, Haitao Pan, Tiancun Xiao, Ting Zhou, Jiao Guo, Zhengquan Su
Format: Artigo
Langue:Inglês
Publié: MDPI AG 2015-07-01
Collection:International Journal of Molecular Sciences
Sujets:
HDL
biomarker
HDL function
reverse cholesterol transport
HDL therapies
Accès en ligne:http://www.mdpi.com/1422-0067/16/8/17245
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires